Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

York, Pennsylvania 17405


Purpose:

Tamsulosin (Flowmax)is approved by the FDA for the treatment for enlarged prostate. Several studies regarding the use of Tamsulosin for the treatment of lower kidney stones have been carried out in the non-Emergency Department setting. This study will compare Tamsulosin 0.4 mg with placebo in regards to rate and time of stone passing and will also look at amount of pain. The purpose of this study is to compare the usefulness of Tamsulosin versus placebo on time to stone passage and pain relief in Emergency Department patients with kidney stones.


Criteria:

Inclusion Criteria: - 18 y.o. or older - diagnosed with a kidney stone less than or equal to 10 mm determined by CT scan - physician has made the decision that you will be discharged to home - must be able to take study medication for up to 10 days and strain your urine - must be able to keep a record of pain medication taken and complete a pain scale rating Exclusion Criteria: - patients currently taking: Tamsulosin (Flowmax), calcium channel blockers, beta blockers, alpha blockers, Sildenaphil (Viagara), Tadalaphil (Cilias), Warfarin (Coumadin, Jantoven), Cimetidine (Tagamet, Tagamet HB) - patients with a clinical and laboratory signs of: urinary tract infection, multiple kidney stones, diabetes, kidney failure, hypotension, pregnancy, fever - patient known to have hypersensitivity to Tamsulosin - patient history of cataract surgery - inability of patient to perform visual pain scale - allergy or intolerance to acetaminophen/oxycodone - patient is unable to understand informed consent - prisoners


NCT ID:

NCT00762424


Primary Contact:

Principal Investigator
Marc Pollack, MD, PhD
WellSpan Health


Backup Contact:

N/A


Location Contact:

York, Pennsylvania 17405
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.